Double Medical(SZ:002901) Sou Hu Cai Jing·2025-10-22 13:03Core Viewpoint - The stock of Dabo Medical (002901) shows a slight increase in price and mixed capital flow, indicating potential investor interest despite some outflows from retail investors [1][2]. Group 1: Stock Performance - As of October 22, 2025, Dabo Medical's stock closed at 52.25 yuan, up by 0.17% with a turnover rate of 0.48% and a trading volume of 13,800 hands, resulting in a transaction amount of 72.41 million yuan [1]. - The capital flow data on October 22 indicates a net inflow of 1.44 million yuan from institutional investors, accounting for 1.99% of the total transaction amount, while retail investors experienced a net outflow of 0.78 million yuan, representing 1.08% of the total [1][2]. Group 2: Recent Capital Flow Overview - Over the past five days, the stock has experienced fluctuating capital flows, with significant net outflows from retail investors on several days, including a net outflow of 26.84 million yuan on October 17 [2]. - The highest net inflow from institutional investors occurred on October 16, amounting to 6.44 million yuan, while the largest net outflow was recorded on October 17 [2]. Group 3: Company Financials and Industry Comparison - Dabo Medical's total market capitalization is 21.63 billion yuan, significantly higher than the industry average of 11.61 billion yuan, ranking 11th out of 124 in the medical device sector [3]. - The company reported a net profit of 244 million yuan for the first half of 2025, reflecting a year-on-year increase of 76.69%, with a gross margin of 71.01%, which is above the industry average of 51.42% [3]. - Dabo Medical's return on equity (ROE) stands at 7.6%, outperforming the industry average of 1.91%, indicating strong profitability relative to its peers [3].